Exporter, Services
Sinopharm Chuankang Pharmaceutical Co., Ltd.
Claim Your Company
China,Shenzhen
Average Lead Time: 15 days
Annual Revenue: US$2.5 Million - US$5 Million
Membership Year: 2004
Plant Area:
5,000-10,000 square meters
Accepted Payment Modes:
USD, CAD, GBP
Certification:
GMP,ISO9001/14001, GMP,ISO9001/14001
Main Products:
Pharmaceutical Chemicals
Sinopharm Chuankang Pharmaceutical Co., Ltd., is a wholly owned subsidiary of Sichuan Industrial Institute of Antibiotics. We relies on the strength of China Pharmaceutical Group and now has become one of the important bases of manufacturing new antibiotics in China.A GMP standard facilities to produce solid/liquid formulations, (tablets, granules, soft/hard capsules) and oral solutions, as well as high potency active pharmaceutical ingredients, fermentation and/or synthetic intermediates are constructed in Chengdu Hi-Tech Park, Western District, and covers an area of 33 ha.In recent years, the company has devoted herself in the fields of bio-immuno-modulators, (including suppressant and enhancers) and cancer therapy adjuvant, such as tacrolimus, mycofenolate mofetil, cyclosporine A, mannatide, ubenimex etc. Of particular notes, the product quality and the specifications of the granisetron hydrochloride have reached international standard.
